PI
NVAX icon

PEAK6 Investments’s Novavax NVAX Stock Holding History

PEAK6 Investments’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$290K Buy
23,000
+4,837
+27% +$62.5K ﹤0.01% 2609
2024
Q2 		$230K Sell
18,163
-11,837
-39% -$119K ﹤0.01% 2687
2024
Q1 		$143K Buy
+30,000
New +$139K ﹤0.01% 3225
2023
Q4 		– Sell
-30,085
Closed -$218K – 4649
2023
Q3 		$218K Buy
30,085
+9,714
+48% +$77.6K ﹤0.01% 3018
2023
Q2 		$151K Buy
+20,371
New +$160K ﹤0.01% 3029
2022
Q4 		– Sell
-19,094
Closed -$337K – 4982
2022
Q3 		$348K Sell
19,094
-26,950
-59% -$1.17M ﹤0.01% 3215
2022
Q2 		$1.47M Buy
+46,044
New +$2.39M ﹤0.01% 2665
2022
Q1 		– Sell
-54,096
Closed -$4.82M – 5740
2021
Q4 		$7.74M Sell
54,096
-2,933
-5% -$504K 0.02% 865
2021
Q3 		$11.8M Buy
57,029
+43,876
+334% +$9.67M 0.03% 626
2021
Q2 		$2.79M Buy
+13,153
New +$2.41M 0.01% 1574

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

PEAK6 Investments's NVAX Position: Q3 2024 in Review

PEAK6 Investments increased its Novavax (NVAX) stake by 27% in Q3 2024, buying an estimated $62.5K and bringing the position to 23,000 shares worth $290K. The position accounts for ﹤0.01% of the portfolio, ranked #2609.

PEAK6 Investments first reported a position in NVAX in Q2 2021 and has held it in 10 quarters since. The position peaked at $11.8M in Q3 2021. 237 funds tracked by Wall St. Rank hold NVAX as of Q3 2024.

  • PEAK6 Investments held 23,000 shares of Novavax worth $290K as of Q3 2024.
  • PEAK6 Investments bought 4,837 Novavax shares in Q3 2024, an estimated $62.5K.
  • Novavax made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2609 holding.
  • PEAK6 Investments first reported a position in Novavax in Q2 2021 and has held it in 10 quarters since.
  • PEAK6 Investments's Novavax position peaked at $11.8M in Q3 2021.
  • 237 funds tracked by Wall St. Rank held Novavax as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.